ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Pharming Group N.V. - ADS, each representing 10 ordinary shares (NQ:PHAR)

14.46 +0.15 (+1.05%)

Streaming Delayed Price Updated: 3:19 PM EDT, Jul 7, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	4,604
Open	14.43
Bid (Size)	14.13 (200)
Ask (Size)	14.47 (100)
Prev. Close	14.31
Today's Range	14.16 - 14.46
52wk Range	9.535 - 21.34
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Pharming Group Q1 Earnings Call Highlights ↗

May 08, 2026

Pharming Group (NASDAQ:PHAR) executives said first-quarter 2026 results reflected an expected decline in RUCONEST revenue tied largely to specialty pharmacy inventory movements and the company’s...

Via MarketBeat

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR

March 03, 2026

From Pomerantz LLP

Via GlobeNewswire

Performance

YTD	-15.6%	-15.6%
1 Month	+13.0%	+13.0%
3 Month	-12.4%	-12.4%
6 Month	-14.0%	-14.0%
1 Year	+46.4%	+46.4%

More News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR

February 24, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR

February 17, 2026

From Pomerantz LLP

Via GlobeNewswire

Pharming Stock Draws Retail Buzz After FDA Seeks More Data For Pediatric Immune Drug — Why Investors Aren’t Panicking ↗

February 02, 2026

Via Stocktwits

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 19, 2025

Via Benzinga

Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday ↗

November 12, 2025

Via Benzinga

Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

September 26, 2025

Via Benzinga

Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket ↗

September 26, 2025

Via Benzinga

Critical Insights From Pharming Analyst Ratings: What You Need To Know ↗

December 09, 2024

Via Benzinga

What Analysts Are Saying About Pharming Stock ↗

March 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 13, 2025

Via Benzinga

G-III Apparel Posts Better-Than-Expected Earnings, Joins Ballard Power Systems, Dollar General And Other Big Stocks Moving Higher On Thursday ↗

March 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 27, 2024

Via Benzinga

Where Pharming Stands With Analysts ↗

October 15, 2024

Via Benzinga

Earnings Scheduled For March 13, 2025 ↗

March 13, 2025

Via Benzinga

European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug ↗

December 11, 2024

Via Benzinga

Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday ↗

August 26, 2024

Via Benzinga

Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 30, 2024

Via Benzinga

PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday ↗

July 30, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

July 30, 2024

Via InvestorPlace

Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗

July 30, 2024

Via Benzinga

Frequently Asked Questions

Is Pharming Group N.V. - ADS, each representing 10 ordinary shares publicly traded?

Yes, Pharming Group N.V. - ADS, each representing 10 ordinary shares is publicly traded.

What exchange does Pharming Group N.V. - ADS, each representing 10 ordinary shares trade on?

Pharming Group N.V. - ADS, each representing 10 ordinary shares trades on the Nasdaq Stock Market

What is the ticker symbol for Pharming Group N.V. - ADS, each representing 10 ordinary shares?

The ticker symbol for Pharming Group N.V. - ADS, each representing 10 ordinary shares is PHAR on the Nasdaq Stock Market

What is the current price of Pharming Group N.V. - ADS, each representing 10 ordinary shares?

The current price of Pharming Group N.V. - ADS, each representing 10 ordinary shares is 14.46

When was Pharming Group N.V. - ADS, each representing 10 ordinary shares last traded?

The last trade of Pharming Group N.V. - ADS, each representing 10 ordinary shares was at 07/07/26 03:19 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.